3rd Quarter - Report

NELSON MULLINS RILEY & SCARBOROUGH for INDIVIOR (FORMERLY, RECKITT BENCKISER PHARMACEUTICALS, INC.)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$10,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 17, 2014 $10,000 Replaced
3rd Quarter - Amendment Oct 17, 2014 $20,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

Any legislation and regulation relating to the treatment of opioid abuse

LobbyistCovered position, as disclosed
RON KLINK —
MICK NARDELLI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Any legislation and regulation relating to the treatment of opioid abuse

LobbyistCovered position, as disclosed
RON KLINK —
MICK NARDELLI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Any legislation and regulation relating to the treatment of opioid abuse

LobbyistCovered position, as disclosed
RON KLINK —
MICK NARDELLI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.